
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1101 | 998 | 1101 | 1118 | 1267 | 1658 |
Fund Return | 10.13% | -0.21% | 10.13% | 3.79% | 4.85% | 5.19% |
Place in category | 1025 | 2329 | 1025 | 140 | 253 | 82 |
% in Category | 34 | 78 | 34 | 7 | 13 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Maj Invest Value Aktier | 3.11B | 21.42 | 5.05 | 8.69 | ||
Maj Invest Vakstaktier | 689.71M | 19.70 | 2.52 | 10.86 | ||
Maj Invest Value Aktier Akk | 1.16B | 21.25 | 4.99 | 8.63 | ||
Maj Invest Global Sundhed | 171.81M | -4.90 | -16.59 | 1.03 | ||
Maj Invest Danske Aktier | 509.14M | 9.95 | -0.39 | 10.86 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LD Aktier Obligationer | 22.18B | -0.27 | 4.27 | 3.78 | ||
Sparinvest SICAV Balance DKK R | 2.48B | -2.59 | 2.34 | 2.25 | ||
Nordea Invest Basis 3 Acc | 11.11B | 10.41 | 1.54 | 5.71 | ||
Jyske Portefolje Balanceret Akk KL | 13.68B | -3.06 | 2.44 | 2.52 | ||
Nordea Invest Basis 2 Acc | 8.9B | 6.83 | -0.27 | 3.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nykredit Realkredit A/S 0.5% | DK0009530248 | 2.69 | - | - | |
Nykredit Realkredit A/S 3% | DK0009537334 | 2.26 | - | - | |
Nykredit Realkredit A/S 1% | DK0009533267 | 2.01 | - | - | |
SoftBank Group Corp. | JP3436100006 | 1.74 | 6,913.0 | +0.71% | |
Alphabet A | US02079K3059 | 1.74 | 157.38 | -1.06% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review